VOV.VN - The Ministry of Health (MoH) on August 17 distributed 30,000 vials of Remdesivir, a broad-spectrum antiviral medication, to intensive care unit (ICU) centres and eight localities in the south to assist them with the COVID-19 fight.

Conglomerate Vingroup recently posted a video on the trial run of its level 4 self-driving electric cars on Hon Tre island, Nha Trang city, the south central province of Khanh Hoa, which is developed by the Vingroup Big Data Institute (VinBigdata).

Two new subsidiaries under the Vietnamese conglomerate VinGroup – the VinES Energy Solutions JSC (VinES) and VinAI Artificial Intelligence Application and Research JSC (VinAI) – have been established with charter capital of VND1,000 billion (US$43.68 million) and VND425 billion, respectively.

Automobile sales in Vietnam plunged in July due to the complications of COVID-19 and social distancing measures being applied in many localities nationwide.

VOV.VN - Vietnam is going to recruit volunteers for clinical trials of ARCT-154 vaccine to see if it is effective against the mutated strain of the Delta variant which was first identified in India and has spread to more than 100 countries worldwide.

VOV.VN - The Health Ministry reported the discovery of additional 5,140 new local COVID-19 cases and 15 imported infections on August 8 morning, raising the coronavirus infection tally in the new pandemic wave to 215,560.

VOV.VN - The Ministry of Health (MoH) has agreed to include Remdesivir, a broad-spectrum antiviral medication, in COVID-19 treatment protocol in Vietnam.

VOV.VN - Approximately 10,000 vials of Remdesivir, a broad-spectrum antiviral drug licensed by the US Food and Drug Administration (FDA) for COVID-19 treatment arrived in Vietnam on August 5 evening.

The Ministry of Industry and Trade has just released a list of factors that are undermining the development of the electric car industry in Vietnam.

VOV.VN - Some of big Indian pharmaceutical companies have agreed to provide Vietnam with approximately 1 million doses of Remdesivir, a broad-spectrum antiviral medication, for COVID-19 treatment.